Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial - Loges, Sonja; Heuser, Michael; Chromik, Jörg; Sutamtewagul, Grerk; Kapp-Schwoerer, Silke; Crugnola, Monica; Di Renzo, Nicola; Lemoli, Roberto; Mattei, Daniele; Fiedler, Walter; Alvarado-Valero, Yesid; Ben-Batalla, Isabel; et al. (Nature Communications, 2025)
Gesehen am 09.07.2025